Crossover, Multiple Dose Pharmacokinetics of Two Curcumin Formulations in Healthy Volunteers
Interventional
Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
AUC
Area under plasma concentration curve from 0-48h using 13 time points.
0-48h
No
Gary N Asher, MD, MPH
Principal Investigator
UNC
United States: Food and Drug Administration
10-2243
NCT01330810
March 2011
April 2012
Name | Location |
---|---|
UNC Department of Family Medicine | Chapel Hill, North Carolina 27599 |